We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+11.4%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$361M
AUM Growth
+$13.5M
Cap. Flow
+$2.7M
Cap. Flow %
0.75%
Top 10 Hldgs %
38.32%
Holding
92
New
22
Increased
23
Reduced
17
Closed
21

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$12.1M
2
CNC icon
Centene
CNC
+$9.16M
3
BIIB icon
Biogen
BIIB
+$9M
4
ABT icon
Abbott
ABT
+$8.96M
5
AMED
Amedisys
AMED
+$8.04M

Top Sells

Rank Stock Value
1
ARNA
Arena Pharmaceuticals Inc
ARNA
+$17.9M
2
MDT icon
Medtronic
MDT
+$10M
3
HOLX
Hologic
HOLX
+$8.86M
4
ZBH icon
Zimmer Biomet
ZBH
+$8.78M
5
ACHC icon
Acadia Healthcare
ACHC
+$8.05M

Sector Composition

Rank Sector Weight
1 Healthcare 97.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MGNX icon
51
MacroGenics
MGNX
$249M
$2.09M 0.58%
130,000
-30,000
-19% -$565K
QURE icon
52
uniQure
QURE
$3.12B
$2.07M 0.57%
+100,000
New +$2.87M
KROS icon
53
Keros Therapeutics
KROS
$211M
$2.05M 0.57%
+35,000
New +$1.75M
FOLD
54
DELISTED
Amicus Therapeutics
FOLD
$2.02M 0.56%
175,000
-250,000
-59% -$2.79M
IMGN
55
DELISTED
Immunogen Inc
IMGN
$1.85M 0.51%
250,000
-50,000
-17% -$311K
AKRO
56
DELISTED
Akero Therapeutics
AKRO
$1.8M 0.5%
85,000
– –
PTCT icon
57
PTC Therapeutics
PTCT
$6.15B
$1.79M 0.5%
45,000
-52,100
-54% -$1.99M
KNSA icon
58
Kiniksa Pharmaceuticals
KNSA
$6.07B
$1.65M 0.46%
+140,000
New +$1.72M
MIRM icon
59
Mirum Pharmaceuticals
MIRM
$5.99B
$1.59M 0.44%
+100,000
New +$1.56M
DTIL icon
60
Precision BioSciences
DTIL
$207M
$1.29M 0.36%
5,833
+1,666
+40% +$465K
ICPT
61
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.22M 0.34%
+75,000
New +$1.26M
KURA icon
62
Kura Oncology
KURA
$882M
$1.19M 0.33%
85,000
+25,000
+42% +$405K
ALKS icon
63
Alkermes
ALKS
$8.26B
$1.16M 0.32%
+50,000
New +$1.31M
LYEL icon
64
Lyell Immunopharma
LYEL
$365M
$1.08M 0.3%
7,000
– –
FMTX
65
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$1.07M 0.3%
75,000
+15,000
+25% +$260K
LXRX icon
66
Lexicon Pharmaceuticals
LXRX
$1.08B
$788K 0.22%
200,000
-150,000
-43% -$729K
CMRX
67
DELISTED
Chimerix, Inc.
CMRX
$707K 0.2%
110,000
+20,000
+22% +$120K
AMRN
68
Amarin Corp
AMRN
$296M
$674K 0.19%
+10,000
New +$828K
DNTH icon
69
Dianthus Therapeutics
DNTH
$6.07B
$399K 0.11%
5,625
– –
MYOV
70
DELISTED
Myovant Sciences Ltd.
MYOV
$389K 0.11%
25,000
-40,000
-62% -$764K
LBPH
71
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$146K 0.04%
30,000
– –
AGIO icon
72
Agios Pharmaceuticals
AGIO
$1.95B
– –
-20,000
Closed -$923K
AVIR icon
73
Atea Pharmaceuticals
AVIR
$404M
– –
-30,000
Closed -$1.05M
COR icon
74
Cencora
COR
$63.7B
– –
-40,000
Closed -$4.78M
DXCM icon
75
DexCom
DXCM
$33.8B
– –
-40,000
Closed -$5.47M
1 2
3
4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Integral Health Asset Management held 92 positions worth $361M, up 3.9% from $348M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Integral Health Asset Management's Q4 2021 filing shows 22 new, 23 increased, 17 reduced and 21 closed positions. Its largest new stake was McKesson: 55,000 shares worth $13.7M. The largest sale was Arena Pharmaceuticals Inc, an estimated $17.9M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, down from 98% a quarter earlier.

  • Integral Health Asset Management's largest Q4 2021 buy was McKesson: 55,000 shares worth $13.7M.
  • Integral Health Asset Management added most to Centene in Q4 2021, an estimated $9.16M increase.
  • Integral Health Asset Management's biggest Q4 2021 reduction was Acadia Healthcare, cutting an estimated $8.05M.
  • Integral Health Asset Management fully exited Arena Pharmaceuticals Inc in Q4 2021, selling an estimated $17.9M.
  • Integral Health Asset Management's ten largest holdings make up 38% of its $361M portfolio in Q4 2021.
  • Integral Health Asset Management opened 22 new positions and closed 21 in Q4 2021.
  • Integral Health Asset Management's portfolio value rose 3.9% quarter-over-quarter to $361M.

Based on Integral Health Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.